Harry Chapman Biography and Net Worth



Harry S. Chapman has served on our Board since August 30, 2010. Mr. Chapman is the Chairman and Chief Executive Officer of Chapman Schewe, Inc., a healthcare insurance and employee benefits consulting firm, and since January 1, 2013, also serves as Managing Director with Higginbotham, an insurance, risk management and financial services firm.  Previously, he served as a Corporate Senior Vice-President and Managed Care Officer of CIGNA’s South Central Region, with responsibility for HMO and PPO plans in several states. Mr. Chapman’s experience also includes having served as head of EQUICOR’s Health Plan and sales operation in Houston and as a Regional Vice-President for Lincoln National Insurance Company’s Central Region.

What is Harry S. Chapman's net worth?

The estimated net worth of Harry S. Chapman is at least $1.08 million as of December 15th, 2022. Mr. Chapman owns 10,900 shares of U.S. Physical Therapy stock worth more than $1,080,081 as of April 20th. This net worth estimate does not reflect any other assets that Mr. Chapman may own. Learn More about Harry S. Chapman's net worth.

How do I contact Harry S. Chapman?

The corporate mailing address for Mr. Chapman and other U.S. Physical Therapy executives is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. U.S. Physical Therapy can also be reached via phone at (713) 297-7000 and via email at [email protected]. Learn More on Harry S. Chapman's contact information.

Has Harry S. Chapman been buying or selling shares of U.S. Physical Therapy?

Harry S. Chapman has not been actively trading shares of U.S. Physical Therapy during the past quarter. Learn More on Harry S. Chapman's trading history.

Who are U.S. Physical Therapy's active insiders?

U.S. Physical Therapy's insider roster includes Harry Chapman (Director), Glenn McDowell (COO), Christopher Reading (CEO), and Graham Reeve (COO). Learn More on U.S. Physical Therapy's active insiders.

Are insiders buying or selling shares of U.S. Physical Therapy?

During the last twelve months, U.S. Physical Therapy insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $82,340.00. During the last twelve months, insiders at the sold shares 11 times. They sold a total of 19,613 shares worth more than $2,050,613.37. The most recent insider tranaction occured on March, 13th when CFO Carey P Hendrickson sold 1,800 shares worth more than $193,104.00. Insiders at U.S. Physical Therapy own 1.8% of the company. Learn More about insider trades at U.S. Physical Therapy.

Information on this page was last updated on 3/13/2024.

Harry S. Chapman Insider Trading History at U.S. Physical Therapy

See Full Table

Harry S. Chapman Buying and Selling Activity at U.S. Physical Therapy

This chart shows Harry S. Chapman's buying and selling at U.S. Physical Therapy by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

U.S. Physical Therapy Company Overview

U.S. Physical Therapy logo
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Read More

Today's Range

Now: $99.09
Low: $97.59
High: $99.26

50 Day Range

MA: $104.57
Low: $93.10
High: $112.87

2 Week Range

Now: $99.09
Low: $78.08
High: $124.11

Volume

61,888 shs

Average Volume

71,875 shs

Market Capitalization

$1.49 billion

P/E Ratio

73.40

Dividend Yield

1.77%

Beta

1.39